Endocrine, behavioral and autonomic effects of neuropeptide AF

Hormones and Behavior

Volumn 56, Issue 1, 2009, Pages 24-34

  Jászberényi, Miklós ^a   Bagosi, Zsolt ^a   Thurzó, Balázs ^a   Földesi, Imre ^a   Szabó, Gyula ^a   Telegdy, Gyula ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

ACTH; Corticosterone; Elevated plus maze; Hypothalamic pituitary adrenal axis; Neuropeptide AF; Open field; Superfusion; Telemetry

Indexed keywords

ANTALARMIN; ASTRESSIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DIAZEPAM; DOPAMINE; HALOPERIDOL; NEUROPEPTIDE; NEUROPEPTIDE AF; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; CORE TEMPERATURE; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DOPAMINE RELEASE; ENDOCRINE SYSTEM; GROOMING; HEART RATE; HORMONE ACTION; HORMONE RESPONSE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOCOMOTION; NONHUMAN; OBSERVATIONAL STUDY; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; REARING; STRIATE CORTEX; TELEMETRY; TEMPERATURE MEASUREMENT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; BRAIN; CENTRAL NERVOUS SYSTEM AGENTS; CORTICOSTERONE; DIAZEPAM; DOPAMINE; DOPAMINE ANTAGONISTS; HALOPERIDOL; HEART RATE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MOTOR ACTIVITY; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; PITUITARY-ADRENAL SYSTEM; PYRIMIDINES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 67349147883     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2009.02.006     Document Type: Article

References (51)

1. Aguilera G., Rabadan-Diehl C., and Nikodemova M. Regulation of pituitary corticotropin releasing hormone receptors. Peptides 22 (2001) 69-74
2. Alonso G., Szafarczyk A., Balmefrezol M., and Assenmacher I. Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats. Brain Res. 397 (1986) 297-307
3. Bakshi V.P., Smith-Roe S., Newman S.M., Grigoriadis D.E., and Kalin N.H. Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. J. Neurosci. 22 (2002) 2926-2935
4. Bujdosó E., Jászberényi M., Farkas J., Tóth G., Wollemann M., and Telegdy G. Behavioral and neuroendocrine actions of the Met-enkephalin-related peptide MERF. Horm. Behav. 43 2 (2003) 302-311
5. Cador M., Marco N., Stinus L., and Simonnet G. Interaction between neuropeptide FF and opioids in the ventral tegmental area in the behavioral response to novelty. Neuroscience 110 2 (2002) 309-318
6. Campbell K.M., McGrath M.J., and Burton F.H. Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion. Brain Res. 833 2 (1999) 216-224
7. Castro S.L., and Zigmond M.J. Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-D-aspartate receptors in substantia nigra. Brain Res. 18; 901 1-2 (2001) 47-54
8. Decker B., Vadokas B., Kutschenreuter U., Golenhofen K., Voigt K., McGregor G.P., and Mandrek K. Action of FMRFamide-like peptides on porcine gastrointestinal motility in vitro. Peptides 18 10 (1997) 1531-1537
9. Desprat C., and Zajac J.M. Hypothermic effects of neuropeptide FF analogues in mice. Pharmacol. Biochem. Behav. 58 2 (1997) 559-563
10. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., and Szekeres P.G. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J. Biol. Chem. 275 (2000) 25965-25971
11. Fukusumi S., Fujii R., and Hinuma S. Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP. Peptides 27 (2006) 1073-1086
12. Granner M.A., and Wooten G.F. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome. Semin. Neurol. 11 (1991) 228-235
13. Hashimoto K., Makino S., Asaba K., and Nishiyama M. Physiological roles of corticotropin-releasing hormone receptor type 2. Endocr. J. 48 (2001) 1-9
14. Horiuchi J., Saigusa T., Sugiyama N., Kanba S., Nishida Y., and Sato Y. Effects of prolactin-releasing peptide microinjection into the ventrolateral medulla on arterial pressure and sympathetic activity in rats. Brain Res. 958 (2002) 201-209
15. Iino K., Oki Y., Tominaga T., Iwabuchi M., Ozawa M., Watanabe F., and Yoshimi T. Stimulatory effect of calcitonin gene-related peptide on adrenocorticotropin release from rat anterior pituitary cells. J. Neuroendocrinol. 10 5 (1998) 325-329
16. Inglis F.M., and Moghaddam B. Dopaminergic innervation of the amygdala is highly responsive to stress. J. Neurochem. 72 (1999) 1088-1094
17. Jászberényi M., Bujdosó E., and Telegdy G. Behavioral, neuroendocrine and thermoregulatory actions of apelin-13. Neuroscience 129 (2004) 811-816
18. Jászberényi M., Bagosi Z., Thurzó B., Földesi I., and Telegdy G. Endocrine and behavioral effects of neuromedin S. Horm. Behav. 52 5 (2007) 631-639
19. Kavaliers M. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice. Neurosci. Lett. 115 2-3 (1990) 307-312
20. Kawamata Y., Fujii R., Fukusumi S., Habata Y., Hosoya M., and Hinuma S. Analyses for susceptibility of rat anterior pituitary cells to prolactin-releasing peptide. Endocrine 12 (2000) 215-221
21. Kelley A.E., Gauthier A.M., and Lang C.G. Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior. Behav. Brain Res. 35 (1989) 27-39
22. Kivipelto L., Majane E.A., Yang H.Y., and Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamide like peptides in the central nervous system of rats. J. Comp. Neurol. 286 2 (1989) 269-287
23. Koob G.F., and Swerdlow N.R. The functional output of the mesolimbic dopamine system. Ann. N. Y. Acad. Sci. 537 (1988) 216-227
24. Lawrence C.B., Celsi F., Brennand J., and Luckman S.M. Alternative role for prolactin-releasing peptide in the regulation of food intake. Nat. Neurosci. 3 (2000) 645-646
25. Lawrence C.B., Ellacott K.L., and Luckman S.M. PRL-releasing peptide reduces food intake and may mediate satiety signaling. Endocrinology 143 2 (2002) 360-367
26. Lawrence C.B., Liu Y.L., Stock M.J., and Luckman S.M. Anorectic actions of prolactin-releasing peptide are mediated by corticotropin-releasing hormone receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 1 (2004) 101-107
27. Lefrere I., De Coppet P., Camelin J.C., Le Lay S., Mercier N., Elshourbagy N., Bril A., Berrebi-Bertrand I., Feve B., and Krief S. Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsiveness. J. Biol. Chem. 277 42 (2002) 39169-39178
28. Liebsch G., Landgraf R., Gerstberger R., Probst J.C., Wotjak C.T., and Engelmann M. Chronic infusion of a CRH (1) receptor anti-sense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul. Peptides 59 (1995) 229-239
29. Lipton J.M., Glyn J.R., and Zimmer J.A. ACTH and alpha-melanotropin in central temperature control. Fed. Proc. 40 13 (1981) 2760-2764
30. Majovski L.V., Jacques S., Hartz G., and Fogwell L.A. Dopaminergic (DA) systems: their role in pathological neurobehavioral symptoms. Neurosurgery 9 (1981) 751-757
31. Matsumoto H., Maruyama M., Noguchi J., Horikoshi Y., Fujiwara K., and Kitada C. Stimulation of corticotropin-releasing hormone-mediated adrenocorticotropin secretion by central administration of prolactin-releasing peptide in rats. Neurosci. Lett. 285 (2000) 234-238
32. Matsuzaki I., Takamatsu Y., and Moroji T. The effects of intracerebroventricularly injected corticotropin-releasing factor (CRF) on the central nervous system: behavioral and biochemical studies. Neuropeptides 13 (1989) 147-155
33. Menzaghi F., Heinrichs S.C., Merlo-Pich E., Tilders F.J., and Koob G.F. Involvement of hypothalamic corticotropin-releasing factor neurons in behavioral responses to novelty in rats. Neurosci. Lett. 168 (1994) 139-142
34. Monnikes H., Heymann-Monnikes I., and Tache Y. CRF in the paraventricular nucleus of the hypothalamus induces dose-related behavioral profile in rats. Brain Res. 574 (1992) 70-76
35. Moreau J.L., Kilpatrick G., and Jenck F. Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport 8 7 (1997) 1697-1701
36. Murase T., Arima H., Kondo K., and Oiso Y. Neuropeptide FF reduces food intake in rats. Peptides 17 2 (1996) 353-354
37. Panula P., Aarnisalo A.A., and Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog. Neurobiol. 48 4-5 (1996) 461-487
38. Panula P., Kalso E., Nieminen M., Kontinen V.K., Brandt A., and Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res. 848 1-2 (1999) 191-196
39. Pellegrino L.J., Pellegrino A.S., and Cushman A.J. Stereotactic Atlas of the Rat Brain (1979), Plenum Press, New York 8-57
40. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 3 (1985) 149-167
41. Pliška V. Models to explain dose-response relationships that exhibit a downturn phase. Trends Pharmacol. Sci. 15 (1994) 178-181
42. Purves H.D., and Sirett N.E. Assay of corticotrophin in dexamethasone-treated rats. Endocrinology 77 (1965) 366-374
43. Reul J.M., and Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2 1 (2002) 23-33
44. Roth B.L., Disimone J., Majane E.A., and Yang H.Y. Elevation of arterial pressure in rats by two new vertebrate peptides FLFQPQRF-NH2 and AGEGLSSPFWSLAAPQRF-NH2 which are immunoreactive to FMRF-NH2 antiserum. Neuropeptides 10 1 (1987) 37-42
45. Sherman J.E., and Kalin N.H. ICV-CRH potently affects behavior without altering antinociceptive responding. Life Sci. 39 (1986) 433-441
46. Skutella T., Criswell H., Moy S., Probst J.C., Breese G.R., Jirikowski G.F., and Holsboer F. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat. Neuroreport 5 (1994) 2181-2185
47. Steckler T., and Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol. Psychiatry 46 (1999) 1480-1508
48. Telegdy G. Neuoropeptides and Brain Function (1984), Karger, Basel
49. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
50. Wiersma A., Baauw A.D., Bohus B., and Koolhaas J.M. Behavioral activation produced by CRH but not alpha-helical CRH (CRH-receptor antagonist) when microinfused into the central nucleus of the amygdala under stress-free conditions. Psychoneuroendocrinology 20 (1995) 423-432
51. Yang H.Y.T., Fratta W., Majane E.A., and Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. 82 (1985) 7757-7761